I can see both sides actually.
Shareholders have waited for a long time and you have to admit, we have been told things in the past and those things simply did not happen or were pushed back or we are still waiting for them to happen.
Shareholder frustration is natural as it involves money - their money
I can also see that some things are beyond the control of the company as well because when you deal with partners, you have to rely on what they do also.
However, that being said, the management team had to know the certification process that has to be followed after the testing, so that could have / should have been explained on the call so everyone would have known the entire process, not just the science. I remember in a PR or a CC, Joe let everyone know all the partners that were in place with manufacturing, etc. It was really detailed and gave me a big confidence boost that they were really serious in lining up manufacturers, etc.. to get the vaccine tested and to market, so they should have done the same with this as well for us. The shareholders would have / should have understood.
Personally, I would like to see a PR with the results, information that it is currently going through the certification process in the US, that after, the IND will be sent to the FDA, that the results HAVE been sent to China or will be next week, China will review and start their work, uplist info and how excited they are in all of this.
We are in the home stretch now I believe. This is where the rubber meets the road and this is where a roadshow needs to kick in for the uplist, where the company takes the next step in showing that it's now playing with the big boys and people take notice.
Shareholders have waited for a long time and you have to admit, we have been told things in the past and those things simply did not happen or were pushed back or we are still waiting for them to happen.
Shareholder frustration is natural as it involves money - their money
I can also see that some things are beyond the control of the company as well because when you deal with partners, you have to rely on what they do also.
However, that being said, the management team had to know the certification process that has to be followed after the testing, so that could have / should have been explained on the call so everyone would have known the entire process, not just the science. I remember in a PR or a CC, Joe let everyone know all the partners that were in place with manufacturing, etc. It was really detailed and gave me a big confidence boost that they were really serious in lining up manufacturers, etc.. to get the vaccine tested and to market, so they should have done the same with this as well for us. The shareholders would have / should have understood.
Personally, I would like to see a PR with the results, information that it is currently going through the certification process in the US, that after, the IND will be sent to the FDA, that the results HAVE been sent to China or will be next week, China will review and start their work, uplist info and how excited they are in all of this.
We are in the home stretch now I believe. This is where the rubber meets the road and this is where a roadshow needs to kick in for the uplist, where the company takes the next step in showing that it's now playing with the big boys and people take notice.
1
